Radiation Protective Effect of an Extract from Chelidonium majus

International Journal of Hematology

Volumn 78, Issue 3, 2003, Pages 226-232

  Song, Jie Young ^a   Yang, Hyun Ok ^b   Shim, Ji Young ^a   Ji Yeon Ahn, ^a   Han, Young Soo ^a   Jung, In Sung ^a   Yun, Yeon Sook ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Chelidonium majus; Hematopoietic; Immunomodulator; Irradiation

Indexed keywords

CHELIDONIUM EXTRACT; CYTOKINE; IMMUNOMODULATING AGENT; INTERLEUKIN 1; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CYCLE; CHELIDONIUM; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC CELL; IMMUNOSTIMULATION; LETHAL DOSE; LYMPHOKINE ACTIVATED KILLER CELL; MITOGENESIS; MOUSE; NONHUMAN; RADIATION PROTECTION; SPLEEN CELL; SURVIVAL; THROMBOCYTE;

CHELIDONIUM MAJUS;

EID: 0142120826     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983799     Document Type: Article

References (27)

1. Chirigos MA, Mastrangelo ML, Mitchell M, Krim M. Progress in Cancer Research and Therapy: Mediation of Cellular Immunity in Cancer by Immune Modifier. Vol 19. New York: Raven; 1982.
2. Hersh EM, Chirigos MA, Masrtangelo MJ. Progress in Cancer Research and Therapy: Augmenting Agents in Cancer Therapy. Vol 16. New York: Raven; 1981.
3. 60Co γ-rays, vinblastine, and cytosine arabinoside. Exp Hematol. 1978;6:2-8.
4. Elkind MM. Repair processes in radiation biology. Radiat Res. 1984;100:425-429.
5. Behling UH. The radioprotective effect of bacterial endotoxin. In: Nowotny A, ed. Beneficial Effects of Endotoxin. New York: Plenum; 1983.
6. Song JY, Yang HO, Pyo SN, Jung IS, Yi SY, Yun YS. Immunomodulatory activity of protein-bound polysaccharide extracted from Chelidonium majus. Arch Pharm Res. 2002;25:158-164.
7. Till JE, McCulloch EA. Early repair processes in marrow cells irradiated and proliferating in vivo. Radiat Res. 1963;18:96-99.
8. Talmadge JE, Herberman RB. The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers. Cancer Treat Rep. 1986;70:171-182.
9. Prasard KN. Handbook of Radiology. Boca Raton FL: CRC Press; 1984.
10. Ross WM, Peeke J. Radioprotection conferred by dextran sulfate given before irradiation in mice. Exp Hematol. 1986;14:147-155.
11. Ainsworth EJ. From endotoxins to newer immunomodulators: survival-promoting effects of microbial polysaccharide complexes in irradiated animals. Pharmacol Ther. 1988;39:223-241.
12. Patchen ML, MacVittie TJ. Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice. Int J Immunopharmacol. 1985;7:923-932.
13. Uglyanitsa KN, Nefydov LI, Doroshenko YM, et al. Ukrain: a novel antitumor drug. Drugs Exp Clin Res. 2000;16:341-456.
14. Santavy F. Alkaloids. In: Stahl E, ed. Thin-Layer Chromatography. Berlin: Springer; 1973:421-471.
15. Kalechman Y, Zuloff A, Albeck M, Strassmann G, Sredni B. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-O-O′)tellurate. Blood. 1995;85:1555-1561.
16. Nakamura W, Kankura T, Eto H. Occult blood appearance in feces and tissue hemorrhage in mice after whole body x-irradiation. Radiat Res. 1971;48:169-178.
17. Nakamura W. Effect of thrombocytes-rich plasma on x-ray induced bone marrow death in mice. Radiat Res. 1973;55:118-128.
18. Neta R, Douches SD, Oppenheim JJ. Interleukin 1 is a radioprotector. J Immunol. 1986;136:2483-2485.
19. Neta R, Oppenheim JJ, Douches SD. Interdependence of the radioprotective effects of human recombinant interleukin-1 alpha, tumor necrosis factor alpha, granulocyte-colony stimulating factor, and murine recombinant granulocyte-colony stimulating factor. J Immunol. 1988;140:108-111.
20. Neta R, Vogel SN, Sipe JD, Wong GG, Nordan RP. Comparison of in vivo effects of human recombinant IL-1 and human recombinant IL-6 in mice. Lymphokine Res. 1988;7:403-412.
21. Metcalf D, Nicola NA. Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: effects of combination with colony stimulating factors. Proc Natl Acad Sci U S A. 1991;88:6239-6243.
22. Neta R, Perlstein R, Vogel SN, Ledney GD, Abrams J. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J Exp Med. 1992;175:689-694.
23. Vogel SN, Douches SD, Kaufman EN, Neta R. Induction of colony stimulating factor in vivo by recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha. J Immunol. 1987;138:2143-2148.
24. Kinnamon KE, Ketterling LL, Stampfli HF, Grenan MM. Mouse endogenous spleen counts as a means of screening for anti-radiation drug. Proc Soc Exp Biol Med. 1980;164:370-373.
25. Neta R, Sztein MB, Oppenheim JJ, Gillis S, Douches SD. The in vivo effects of interleukin-1, I: bone marrow cells induced to cycle after administration of interleukin-1. J Immunol. 1987;139:1861-1866.
26. Metcalf D. The molecular biology and functions of the granulocytes macrophage colony stimulating factors. Blood. 1986;67:257-267.
27. Metcalf D, Moore MAS. Haemopoietic Cells. Amsterdam: North Holland; 1971. Frontiers in Biology; vol 24.